|
|
|
Insider
Information: |
Aryeh Jason |
Relationship: |
Director |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
401,047 |
|
Indirect Shares
|
890,847 |
|
|
Direct
Value |
$6,969,474 |
|
|
Indirect Value
|
$4,813,368 |
|
|
Total
Shares |
1,291,894 |
|
|
Total
Value |
$11,782,842 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ligand Pharmaceuticals Inc |
LGND |
Director |
2024-04-30 |
76,828 |
2024-04-30 |
56,619 |
Premium* |
|
Vaxart Inc |
VXRT |
Director |
2010-12-27 |
0 |
2011-03-15 |
131,783 |
Premium* |
|
Myrexis Inc |
MYRX |
Director |
|
0 |
2012-06-15 |
552,145 |
Premium* |
|
Novelion Therapeutics Inc |
NVLN |
Director |
2017-05-15 |
242,433 |
2017-05-15 |
150,300 |
Premium* |
|
Aralez Pharmaceuticals Inc. |
ARLZ |
Director |
2017-05-23 |
15,000 |
2017-05-23 |
0 |
Premium* |
|
Merrimack Pharmaceuticals Inc |
MACK |
See Explanation of Res... |
2019-07-16 |
3,802 |
2019-07-11 |
0 |
Premium* |
|
Orchestra BioMed Holdings Inc. |
OBIO |
Director |
2023-04-12 |
62,984 |
2023-01-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
175 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MYRX |
Myrexis Inc |
Director |
|
2011-11-03 |
4 |
OE |
$5.00 |
$6,000 |
I/I |
1,200 |
69,066 |
0 |
- |
|
MYRX |
Myrexis Inc |
Director |
|
2011-11-11 |
4 |
B |
$2.65 |
$6,635 |
I/I |
2,500 |
71,566 |
2.1 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2010-06-01 |
4 |
B |
$1.48 |
$7,400 |
D/D |
5,000 |
86,574 |
2.39 |
- |
|
MYRX |
Myrexis Inc |
Director |
|
2011-11-19 |
4 |
OE |
$7.50 |
$7,500 |
I/I |
1,000 |
82,266 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2012-06-01 |
4 |
B |
$11.98 |
$8,386 |
I/I |
700 |
285,036 |
2.1 |
- |
|
MYRX |
Myrexis Inc |
Director |
|
2012-06-14 |
4 |
B |
$2.36 |
$9,450 |
I/I |
4,000 |
541,220 |
2.1 |
- |
|
MYRX |
Myrexis Inc |
Director |
|
2012-05-30 |
4 |
B |
$2.47 |
$9,909 |
I/I |
4,020 |
525,971 |
2.1 |
- |
|
MYRX |
Myrexis Inc |
Director |
|
2012-03-17 |
4 |
OE |
$5.00 |
$10,000 |
I/I |
2,000 |
497,536 |
0 |
- |
|
NVLN |
Novelion Therapeutics Inc |
Director |
|
2012-09-22 |
4 |
OE |
$10.00 |
$10,000 |
I/I |
1,000 |
154,578 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2010-05-25 |
4 |
B |
$1.43 |
$10,750 |
D/D |
7,500 |
55,595 |
2.39 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2010-12-15 |
4 |
S |
$5.74 |
$10,946 |
I/I |
(1,907) |
179,876 |
0 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2010-12-15 |
4/A |
S |
$5.74 |
$10,946 |
D/D |
(1,907) |
15,093 |
0 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2010-06-11 |
4 |
S |
$5.74 |
$12,324 |
I/I |
(2,147) |
249,478 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2011-03-15 |
4 |
B |
$9.47 |
$14,235 |
I/I |
1,500 |
272,611 |
2.1 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2010-11-22 |
4 |
S |
$5.25 |
$14,868 |
I/I |
(2,832) |
193,188 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2011-03-10 |
4 |
B |
$10.01 |
$15,125 |
I/I |
1,500 |
3,025 |
2.1 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2010-01-07 |
4 |
AS |
$5.29 |
$18,213 |
I/I |
(3,443) |
733,577 |
0 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2010-03-08 |
4 |
AS |
$5.75 |
$18,393 |
I/I |
(3,200) |
584,220 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2011-05-12 |
4 |
B |
$10.96 |
$18,906 |
I/I |
1,725 |
281,336 |
2.1 |
- |
|
MACK |
Merrimack Pharmaceuticals... |
See Explanation of Responses |
|
2019-07-12 |
4 |
B |
$5.62 |
$19,324 |
D/D |
3,400 |
3,500 |
2.37 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2011-03-14 |
4 |
S |
$5.82 |
$19,828 |
I/I |
(3,400) |
136,683 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2011-08-10 |
4 |
B |
$10.57 |
$21,140 |
I/I |
2,000 |
283,336 |
2.1 |
- |
|
VXRT |
Vaxart Inc |
Director |
|
2009-12-16 |
4 |
S |
$5.24 |
$21,196 |
I/I |
(4,045) |
787,420 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2007-05-30 |
4 |
B |
$6.48 |
$21,708 |
I/I |
3,350 |
12,150 |
2.1 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2011-11-10 |
4 |
B |
$10.90 |
$21,910 |
I/I |
2,000 |
5,025 |
2.1 |
- |
|
175 Records found
|
|
Page 3 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|